Valeria Tovazzi

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Impact of baseline nutritional and inflammatory markers on safety and efficacy of immune checkpoint inhibitors in cancer patients: a retrospective, monocentric study.

Impact of baseline nutritional and inflammatory markers on safety and efficacy of immune checkpoint inhibitors in cancer patients: a retrospective, monocentric study.

Journal: Discover oncology

Published: October 01, 2025

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial.

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 09, 2024

Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors.

Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors.

Journal: Journal of bone oncology

Published: July 11, 2024

Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.

Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.

Journal: Endocrine-related cancer

Published: June 03, 2021

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic.

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic.

Journal: Frontiers in oncology

Published: May 09, 2021

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 06, 2021

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

Journal: Journal for immunotherapy of cancer

Published: February 05, 2021

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome.

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome.

Journal: Endocrine

Published: December 06, 2020

The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures.

The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures.

Journal: Frontiers in oncology

Published: June 08, 2020

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Journal: Cancer discovery

Published: May 29, 2020

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report.

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report.

Journal: Frontiers in oncology

Published: March 30, 2020

Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view.

Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view.

Journal: Endocrine

Published: March 25, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026